Culturing circular ssDNA viruses for the production of vaccines

Details Culturing circular ssDNA viruses for the production of vaccines Culturing circular ssDNA viruses for the production of vaccines

2007-11-27

2007-11-27

Mosher, Mary E. (Department: 1648)

Chemistry: molecular biology and microbiology

Virus or bacteriophage, except for viral vector or...

Recovery or purification

C424S204100

Reexamination Certificate

active

11275842

ABSTRACT:
The present invention relates to the use of interferon in the in vitro cultivation of animal circular ssDNA virus such as Porcine Circovirus 2 or human TT virus in an animal cell line. Increased titres of animal circular ssDNA virus are obtained by addition of interferons or agents which ensure the production of endogenous interferons by said cell line.

REFERENCES:
patent: WO 01/16330 (2001-03-01), None
Darwich et al., “Cytokine profiles of peripheral blood mononuclear cells from pigs with postweaning multisystemic wasting syndrome in response to mitogen, superantigen or recall viral antigens,” Journal of General Virology, 84, pp. 33453-33457 (2003).
Allan et al. “Experimental infection of colostrum deprived piglets with porcine circovirus 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) potentiates PCV2 replication.”Archives of Virology145: 2421-2429 (2000).
Fenaux et al. “A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.”J. Virol.78: 6297-6303 (2004).
Meerts et al. “Enhancement of porcine circovirus 2 replication in porcine cell lines by IFN-γ before and after treatment and by IFN-α after treatment.”J. of Interferon and Cytokine Research25: 684-693 (2005).
Extended European Search Report (EPO Form 1507N) for EP Application No. 06002030.2, May 30, 2006.
Allan et al. “Experimental Infection of colostrum deprived piglets with porcine circovirus 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) potentiates PCV2 replication,” (2000) Arch Virol. 145, 2421-2429.
Allan et al. “A sequential study of experimental infection of pigs with porcine circovirus and porcine parvovirus: immunostaining of cryostat sections and virus isolation,” (2000) J Vet Med B. 47, 81-94.
Allan et al. “Pathogenesis of porcine circovirus; experimental infections of colostrum deprived piglets and examination of pig foetal material,” (1995) Vet. Microbiol. 44, 49-64.
Biaglni “Human circoviruses,” (2004) Vet. Microbiol. 98, 95-2004.
Blanchard et al. “Protection of swine against post-weaning multisystemic wasting syndrome (PMVVS) by porcine circovirus type 2 (PCV2) proteins,” (2003) Vaccine 21, 4565-4575.
Familletti et al. “A convenient and rapid cytopathic effect inhibition assay for interferon,” (1981) Methods in Enzymology 78, 387-394.
Krakowka et al. “Activation of the immune system is the pivotal event in the production of wasting disease in pigs infected with porcine circovirus-2 (PCV-2),” (2001) Vet Pathol. 38, 31-42.
Larghi et al. “Rabies virus inactivation by binary ethylenimine: new method for inactivated vaccine production,” (1980) J. Clin Microbiol 11, 120-122.
Lefevre et al. “Production, purification and biological properties of anEscherichia coli-derived recombinant porcine alpha interferon,” (1990) J Gen Virol. 71, 1057-1063.
Meehan et al. “Characterization of novel circovirus DNAs associated with wasting syndromes in pigs,” (1998) J. Gen Virol. 79, 2171-2179.
Misinzo et al. “Binding and entry characteristics of porcine circovirus 2 in cells of the porcine monocytic line 3D4/31,” (2005) J. Gen Virol 86, 2057-68.
Moreno et al. “Response of TT virus to IFN plus ribavirin treatment in patients with chronic hepatitis C,” World J. Gastroenterol (2004) 1, 143-146.
Pestka. “Interferon standards and general abbreviations,” (1986) Methods in Enzymology 119, 14-23.
Rubinstein et al. “Convenient assay for interferons,” (1981) J. Virol. 37, 755-758.
Sanchez et al. “Change of porcine circovirus 2 target cells in pigs during development from fetal to early postnatal life,” (2003) Vet Microbiol 95, 15-25.
Scodeller et al. “Inactivation of foot-and-mouth disease virus vaccine strains by activation of virus-associated endonuclease,” (1984) J. Gen Virol., 65, 1567-1573.
Shibayama et al. “Inverse relationship between the titre of TT virus DNA and the CD4 cell count in patients infected with HIV,” (2001) AIDS 15, 563-570.
Touinssi et al. “TT virus infection: prevalence of elevated viraemia and arguments for the immune control of viral load,” J. Clin Virol. (2001) 21, 135-141.
Verfaillie et al. “Comparative analysis of porcine cytokine production by mRNA and protein detection,” (2001) Vet Immunol Immunopathol, 38, 57-73.
Von Neiderhausern et al. “Cloning and expression in mammalian cells of porcine tumor necrosis factor alpha: examination of biological properties,” (1993) Vet Immunol Immunopathol, 38, 57-73.
Weingartl et al. “Continuous porcine cell lines developed from alveolar macrophages: Partial characterization and virus susceptibility,” (2002) J. Virol Methods. 10, 203-216.
Xia et al. “Cloning and expression of interferon-α/γ from a domestic porcine breed and its effect on classical swine fever virus,” (2005) Vet Immunol Immunopathol. 104, 81-89.

Affiliated with

Also associated with

Rating

Culturing circular ssDNA viruses for the production of vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Culturing circular ssDNA viruses for the production of vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Culturing circular ssDNA viruses for the production of vaccines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3863510